
OrganiGram Holdings OGI
$ 1.16
1.32%
Quarterly report 2024-Q3
added 05-06-2026
OrganiGram Holdings Cash Conversion Cycle 2011-2026 | OGI
Annual Cash Conversion Cycle OrganiGram Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 2.92 K | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.92 K | 2.92 K | 2.92 K |
Cash Conversion Cycle of other stocks in the Drug manufacturers industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Endo International plc
ENDP
|
141 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
55.1 | - | - | $ 36.6 M | ||
|
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
-38 | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
-4.1 K | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-224 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
460 | - | - | $ 754 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
-227 | $ 6.23 | 4.11 % | $ 92.5 M | ||
|
Agile Therapeutics
AGRX
|
-206 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
-128 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
61.7 | $ 2.85 | 0.35 % | $ 1.09 B | ||
|
Athenex
ATNX
|
137 | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
-46.2 | $ 34.9 | -1.38 % | $ 1.28 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
192 | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
110 | - | - | $ 11.5 B | ||
|
Eagle Pharmaceuticals
EGRX
|
139 | - | -39.89 % | $ 27.7 M | ||
|
Bausch Health Companies
BHC
|
79.8 | $ 5.32 | -1.76 % | $ 1.97 B | ||
|
Pacira BioSciences
PCRX
|
209 | $ 23.53 | -0.63 % | $ 1.09 B | ||
|
Organogenesis Holdings
ORGO
|
106 | $ 2.57 | -1.95 % | $ 326 M | ||
|
Canopy Growth Corporation
CGC
|
177 | $ 1.1 | -2.23 % | $ 118 M | ||
|
Aurora Cannabis
ACB
|
1.45 K | $ 3.61 | -1.63 % | $ 198 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
150 | $ 1.15 | 3.15 % | $ 1.43 M | ||
|
Jupiter Wellness
JUPW
|
-186 | - | - | $ 33.6 M | ||
|
Tilray
TLRY
|
169 | $ 5.59 | -1.06 % | $ 3.45 B | ||
|
Lannett Company
LCI
|
173 | - | 1.15 % | $ 7.11 M | ||
|
Evolus
EOLS
|
74.8 | $ 6.63 | 0.91 % | $ 427 M | ||
|
Emergent BioSolutions
EBS
|
360 | $ 9.32 | 1.47 % | $ 499 M | ||
|
Veru
VERU
|
19.6 | $ 2.34 | 0.86 % | $ 34.3 M | ||
|
cbdMD
YCBD
|
83 | $ 0.8 | -1.78 % | $ 3.22 M | ||
|
Assertio Holdings
ASRT
|
467 | $ 23.44 | -0.02 % | $ 150 M | ||
|
ProPhase Labs
PRPH
|
96 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
-35 | - | - | $ 1.42 B | ||
|
PetIQ
PETQ
|
53.8 | - | 1.64 % | $ 400 M | ||
|
Recro Pharma
REPH
|
105 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
314 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
2.74 | $ 0.75 | 1.58 % | $ 37.5 M | ||
|
PLx Pharma
PLXP
|
113 | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
150 | $ 16.18 | 0.47 % | $ 18.8 B | ||
|
Zomedica Corp.
ZOM
|
154 | - | -0.21 % | $ 98 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
14.6 K | - | - | $ 55.5 M | ||
|
Rockwell Medical
RMTI
|
57 | $ 0.74 | -1.72 % | $ 26.6 M | ||
|
China Pharma Holdings
CPHI
|
139 | $ 0.81 | 4.67 % | $ 3.48 M | ||
|
TherapeuticsMD
TXMD
|
-723 | $ 2.07 | -1.9 % | $ 23.9 M |